Investigational Drug Details
| Drug ID: | D325 |
| Drug Name: | Benzocaine |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB01086 |
| DrugBank Description: | A surface anesthetic that acts by preventing transmission of impulses along nerve fibers and at nerve endings. |
| PubChem ID: | 2337 |
| CasNo: | 94-09-7 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CCOC(=O)C1=CC=C(N)C=C1 |
| Structure: |
|
| InChiKey: | BLFLLBZGZJTVJG-UHFFFAOYSA-N |
| Molecular Weight: | 165.1891 |
| DrugBank Targets: | Sodium channel protein type 10 subunit alpha |
| DrugBank MoA: | Benzocaine binds to sodium channels and reversibly stabilizes the neuronal membrane which decreases its permeability to sodium ions. Depolarization of the neuronal membrane is inhibited thereby blocking the initiation and conduction of nerve impulses. |
| DrugBank Pharmacology: | Benzocaine is a local anesthetic commonly used as a topical pain reliever. It is the active ingredient in many over-the-counter analgesic ointments. It is also indicated for general use as a lubricant and topical anesthetic on intratracheal catheters and pharyngeal and nasal airways to obtund the pharyngeal and tracheal reflexes; on nasogastric and endoscopic tubes; urinary catheters; laryngoscopes; proctoscopes; sigmoidoscopes and vaginal specula. |
| DrugBank Indication: | For general use as a lubricant and topical anesthetic on esophagus, larynx, mouth, nasal cavity, rectum, respiratory tract or trachea, urinary tract, vagina. It is also used to suppress gag reflex. |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|